NCT06890013Recruiting
A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices
Identifying the Role of Flow Mediated Dilatation Assessment in Acute Coronary Syndromes - Evaluation of the Cor-IS Technology (the FLARE-ACS Trial)
Source: ClinicalTrials.gov · Last updated 2 Mar 2026
Brief summary (registry, in English)
A prospective, single-center, observational study aiming to assess the predictive role of flow mediated dilatation in acute coronary syndromes, combined with echocardiographic and biochemical indices. The novel Cor-IS technology will also be evaluated.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 17 Mar 2025
- Start date
- 1 Jun 2024
- Primary completion date
- 1 Jun 2026
- Lead sponsor
- Aristotle University Of Thessaloniki
- Diseases
- Coronary artery disease
- NCT number
- NCT06890013
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Jun 2024 to the primary completion date, 1 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of intravenous drugs
Other illness
- Patients with acute coronary syndromes classified as MINOCA, or type II myocardial infarction
- Patients with rare acute coronary syndrome types, such as spontaneous coronary artery dissection or Takotsubo syndrome
- Patients with congenital heart disease
- Patients with end stage chronic kidney disease
- Patients with active malignancy or autoimmune diseases which limit their survival
Age
- Age \> 85 years
Other
- Patients with expected survival \< 1 year due to other reasons
- Suboptimal echocardiographic windows
- Inability to provide written consent
- Inability to comply with the follow-up schedule of the study
- Pregnancy
Who the study is looking for
- Age \> 18 years
- Patients hospitalized due to acute coronary syndrome (STEMI, NSTEMI)
- Capability of providing written informed consent
- Patients able to comply with the follow-up schedule of the study
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ippokratio General Hospital Coordinator of this site? Confirm its status | Thessaloniki | Greece | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.